| mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
4e-07 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
4e-05 |
| mRNA |
TAE684 |
CCLE |
pan-cancer |
AAC |
0.19 |
8e-05 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |